Post-Market Real-World Evidence Registry for the NeuroOne OneRF® Ablation System for Epilepsy

← catalyst calendar

NCT07546253 · readout ≤ 712 d

Sponsored by NeuroOne Medical Technologies Corporation (industry) · NMTC — their whole pipeline →.

Phase

—

Status

Not yet recruiting

Study type

Observational

Enrollment

100estimated

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis

Date

Filed

Basis

What it is

Start

Jul 2026

estimated

When the study began enrolling

Primary completion

Jul 2028

estimated

The date the last participant is measured for the primary outcome — the readout window

Study completion

Jul 2028

estimated

The whole study's end, after follow-up

First posted

2026-04-22

actual

When this record first appeared on the registry

Results posted

—

When the sponsor posted results to the registry

Record updated

2026-04-22

actual

The sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Conditions

Drug Resistant Epilepsy
Refractory Epilepsy

Intervention

Other: Participants are not assigned an intervention as part of the study.

Primary outcomes

what the primary-completion date above is the date OF

Evaluate seizure outcomes

measured baseline to up to one (1) year

Evaluate changes in seizure frequency

measured baseline to up to one (1) year

Evaluate changes in seizure severity

measured baseline to up to one (1) year

Evaluate antiseizure medication

measured baseline to up to one (1) year

Gather product deficiency and patient safety events

measured From enrollment through the completion of follow-up visits (approximately a one-year period)

Publications

PMID 41785222 — cited as background

Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.

Permalink · NMTC's whole pipeline · Catalyst calendar · Every registered study · What changed